InVitro Cell Research, LLC’s Post

Everlume Solves Problems for Families Facing Rare Diseases! At Everlume, we believe families fighting rare diseases deserve answers without delays. That’s why we implement a NO QUEUE policy—putting patients first and delivering prompt results. What Makes Us Different? Personalized Communication & Adaptability: Seamlessly guiding you through the complex drug discovery process. Exclusive Science Teams: Access a dedicated group of experts tailored to your project. Cutting-Edge Rare Disease Lab: Specialized solutions for your rare disease challenges. Proven Results: We have an accomplished science team that has played pivotal roles in developing over 100 potential drug products. Families should never feel frustrated or powerless. We’re the guide you need to navigate toward solutions, hope, and progress. Learn more about how Everlume can accelerate your rare disease journey. https://hubs.ly/Q02__SDW0 #RareDisease #DrugDiscovery #InnovativeSolutions #PrecisionMedicine #HealthcareInnovation #NoQueuePolicy #FamiliesFirst #RareDiseaseLab #ScienceWithPurpose #Everlume

"We were not going to focus on trying to develop new drugs from scratch. We didn't have a billion dollars and we didn't have 10 years to wait." - Dr. @DavidFajgenbaum, co-founder & president of @EveryCure. David shares his personal struggle with a previously untreatable disease and the solutions-based thinking that helped him develop AI to identify potential matches between existing medicines and diseases. Read his story: https://ow.ly/mPmi50SzU90

In a new study, people with systemic lupus erythematosus (SLE) who developed the disease later in life exhibited notable clinical differences and lower disease activity, however, they also have the lowest survival rate...Click the link to continue reading the article. 👉 https://bit.ly/3V3uOCL #lupus #lupusawareness #news #Ohio #lupusgreateroh #lupusresarch #sciencenews #science

𝐀𝐧𝐲𝐨𝐧𝐞 𝐜𝐚𝐧 𝐛𝐞 𝐚 𝐬𝐜𝐢𝐞𝐧𝐭𝐢𝐬𝐭. 𝐁𝐞𝐥𝐢𝐞𝐯𝐞 𝐢𝐭 𝐨𝐫 𝐧𝐨𝐭💡 Today, I stumbled upon a TedTalk video that popped up on my YouTube feed. I clicked on it out of pure curiosity, not expecting much, but what I watched lit a spark in me, and prompted me to share her amazing story with everyone. Meet Dr Sonia Vallabh. She started as a lawyer and now dives deep into biomedical research. The moment she lost her mother to a rare brain disease, and learned she carried the same genetic mutation, she knew she couldn't wait for a miracle. With a mix of fear and determination, she and her husband quit their jobs to build The Broad Institute from the ground up — a research lab focused on studying Major Prion Proteins (PrP) in order to find a cure. The prion disease, called Fatal Familial Insomnia (or more well-known as Creutzfeldt-Jakob disease) was a result of a random mutation in one's DNA — an adenine (A) nucleotide where there should be a guanine (G) nucleotide. Armed with this knowledge, the husband and wife duo believe that by cutting out the PrP proteins entirely, it would be a promising solution to prevent the protein from misfolding in the first place, greatly reducing the likelihood of triggering the disease at all. While life often feels like a series of obstacles we can't control, there's something powerful within our grasp - how we react to these hurdles. She taught us that when passion fuels your actions, and when you leverage science to uplift others, you even have the potential to alter your own fate. Do show Dr Vallabh all your love and support as every bit counts! Raising awareness for her work is crucial can help to accelerate her journey towards finding a treatment for this once-thought incurable disease. 🎥 Watch Dr Vallabh's TedTalk Video here: https://lnkd.in/gVkh7DkD 💰 Fund Prion disease research here: https://lnkd.in/gymj6yDH #biotech #research #biotechnology #prion #disease #diseaseresearch #biomedical #science #biology #scientist #inspiration

"𝑨𝒅𝒗𝒂𝒏𝒄𝒆𝒅 𝑫𝒊𝒂𝒈𝒏𝒐𝒔𝒕𝒊𝒄 𝑻𝒐𝒐𝒍𝒔 𝒊𝒏 𝑨𝒐𝒓𝒕𝒊𝒄 𝑷𝒂𝒕𝒉𝒐𝒍𝒐𝒈𝒚: 𝑰𝒏𝒕𝒆𝒈𝒓𝒂𝒕𝒊𝒏𝒈 3𝑫 𝑷𝒓𝒊𝒏𝒕𝒊𝒏𝒈, 𝑽𝒊𝒓𝒕𝒖𝒂𝒍 𝑹𝒆𝒂𝒍𝒊𝒕𝒚, 𝑮𝒆𝒏𝒆𝒕𝒊𝒄 𝑻𝒆𝒔𝒕𝒊𝒏𝒈, 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍 𝑰𝒏𝒔𝒊𝒈𝒉𝒕𝒔, 𝑯𝒆𝒂𝒍𝒕𝒉 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚 𝑨𝒔𝒔𝒆𝒔𝒔𝒎𝒆𝒏𝒕𝒔, 𝒂𝒏𝒅 𝑳𝒆𝒈𝒂𝒍 𝑷𝒆𝒓𝒔𝒑𝒆𝒄𝒕𝒊𝒗𝒆𝒔" A sincere thank you to Giuseppe Astori and Angela Bozza for their contribution to the chapter "Bioprinting Research in Aortic Diseases." Their insights into bioprinting open new possibilities in aortic disease treatment and research.

Melioidosis ('Soil Fever') is a potentially fatal disease caused by Burkholderia pseudomallei, a gram negative bacteria, and affecting people engaged in agriculture or farming and those with comprbidities like diabetes and chronic lung/kidney/liver/heart diseases. This documentary prepared by Kasturba Medical College, Manipal / Manipal Academy of Higher Education/ Center for Emerging and Tropical Diseases led by Chiranjay Mukhopadhyay, raises awareness about emphasizing the importance of early diagnosis and treatment. Through real-life stories, it underscores the significance of prompt medical intervention, highlighting the powerful message: "ONE diagnosed, ONE saved." Dr Mukhopadhyay, a clinical microbiologist and reseaecher from Manipal, as well as a research collaborator of GlohMed, provides clear information on melioidosis burden in South asia in the attached video. #glohmed #melioidosis #burkholderia https://lnkd.in/dJj4Dvph

On yesterday’s “Emerging Treatments” panel we were lucky enough to hear from a lupus warrior (who is a doctor in her spare time). Lupus killed her childhood. So she stopped asking “why me?” and started asking “why not me?” and now champions involvement in lupus research. 💜 Key learning from patients yesterday: When you have a disease that flares, sometimes you are too sick and other times you’re not sick enough to qualify for a clinical trial. We need to fix this! #lupus #lupusawareness #lupusadvocacy #patientadvocacy #clinicaltrials

(Português no 1º comentário) 📚📲 This links is more than a shared accomplishment: it's a chance to reach more people in other parts of the world through journalism. Here are 5 of my articles published in an international book. In 2023, I was selected for the National Press Foundation's Covering Rare Diseases fellowship, along with 24 other journalists from 21 countries. The stories produced after the fellowship are now collected in the book "Living with a Rare Disease Worldwide", Volume 3, published by the Fondation Ipsen I wrote a series of 5 articles on Rare Diseases in Childhood, which were published in Portuguese in Terra in February and are now included in the book in English.  You can download the digital version of the book for free and also read the work of colleagues from other countries who have brought their perspective on the reality in their countries. Covering the topic of rare childhood diseases allowed me to hear many touching personal experiences. In addition to the articles, the book is now helping to spread these stories by connecting even more families, in the hope of mobilizing society to demand more effective public policies. https://lnkd.in/dZsAYzFQ

In this operative video, I describe aggressive resection of gliomas affecting the paracentral lobule. This is a young patient who presented with a seizure and was unfortunately diagnosed with a low-grade glioma affecting the posterior aspect of the paracentral lobule. Log in now to discover more | https://bit.ly/4aeIa56.

Check out this groundbreaking discovery by Israeli researchers! They have identified markers for Parkinson's disease that can detect it 15 years before symptoms appear. If you are for boycotting Israel, forget about it. I suppose the boycotters who suffer from Parkinson's will forget 😉. Click the link below to learn more. #ParkinsonsResearch #MedicalBreakthroughs 👉 https://lnkd.in/em_tpAFt #ParkinsonsDisease #HealthcareInnovation #ResearchDiscovery 🧠🔬